loader
Please Wait
Applying Filters...
menu
    • menu

    Setid 2e9dc175 80cb B598 D035 4c3d5134c096 Applno 208624 Form Tablet Extended Release Oral Dosage Eq 200mg Base 8 33mg 50mg 33 33mg - Drug Product Composition: Ombitasvir

    Menu

    Ombitasvir

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 208624 / DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 200MG BASE;8.33MG;50MG;33.33MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**